Edition:
United Kingdom

People: Biogen Inc (BIIB.OQ)

BIIB.OQ on NASDAQ Stock Exchange Global Select Market

226.39USD
18 Apr 2019
Change (% chg)

$-0.79 (-0.35%)
Prev Close
$227.18
Open
$227.28
Day's High
$227.80
Day's Low
$221.56
Volume
1,219,471
Avg. Vol
704,725
52-wk High
$388.67
52-wk Low
$216.13

Denner, Alexander 

Dr. Alexander J. Denner, Ph.D. is an Independent Director of Biogen Inc. Dr. Denner has served as one of our directors since 2009. Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP, a registered investment advisor, which he founded in 2012. Sarissa Capital focuses on improving the strategies of companies to better provide shareholder value. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital. Prior to that, he served as a portfolio manager at Viking Global Investors, a private investment fund, and Morgan Stanley Investment Management, a global asset management firm. Dr. Denner is also a director of The Medicines Company, a biopharmaceutical company. Dr. Denner has significant experience overseeing the operations and research and development of healthcare companies and evaluating corporate governance matters. He also has extensive experience as an investor, particularly with respect to healthcare companies, and possesses broad healthcare industry knowledge.

Basic Compensation

Total Annual Compensation, USD 134,000
Restricted Stock Award, USD 269,479
Long-Term Incentive Plans, USD --
All Other, USD 17,000
Fiscal Year Total, USD 420,479

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --